Difference between revisions of "IgG4-related systemic diseases"

From Libre Pathology
Jump to navigation Jump to search
Line 5: Line 5:
*[[Retroperitoneal fibrosis]].<ref name=pmid18609677>{{Cite journal  | last1 = Kamisawa | first1 = T. | last2 = Okamoto | first2 = A. | title = IgG4-related sclerosing disease. | journal = World J Gastroenterol | volume = 14 | issue = 25 | pages = 3948-55 | month = Jul | year = 2008 | doi =  | PMID = 18609677 }}</ref>
*[[Retroperitoneal fibrosis]].<ref name=pmid18609677>{{Cite journal  | last1 = Kamisawa | first1 = T. | last2 = Okamoto | first2 = A. | title = IgG4-related sclerosing disease. | journal = World J Gastroenterol | volume = 14 | issue = 25 | pages = 3948-55 | month = Jul | year = 2008 | doi =  | PMID = 18609677 }}</ref>
*[[Riedel's thyroiditis]].
*[[Riedel's thyroiditis]].
*[[Inflammatory pseudotumour]] (inflammatory myofibroblastic tumour)<ref name=pmid18609677/> - possibly.<ref name=pmid21297584>{{Cite journal  | last1 = Saab | first1 = ST. | last2 = Hornick | first2 = JL. | last3 = Fletcher | first3 = CD. | last4 = Olson | first4 = SJ. | last5 = Coffin | first5 = CM. | title = IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? | journal = Mod Pathol | volume = 24 | issue = 4 | pages = 606-12 | month = Apr | year = 2011 | doi = 10.1038/modpathol.2010.226 | PMID = 21297584 }}</ref>
*[[Inflammatory pseudotumour]],<ref name=pmid18609677/> also known as ''inflammatory myofibroblastic tumour'' (''IMT''); probably only a subset of IMT.<ref name=pmid21297584>{{Cite journal  | last1 = Saab | first1 = ST. | last2 = Hornick | first2 = JL. | last3 = Fletcher | first3 = CD. | last4 = Olson | first4 = SJ. | last5 = Coffin | first5 = CM. | title = IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? | journal = Mod Pathol | volume = 24 | issue = 4 | pages = 606-12 | month = Apr | year = 2011 | doi = 10.1038/modpathol.2010.226 | PMID = 21297584 }}</ref>


*Sclerosing cholangitis<ref name=pmid18609677/> (IgG4-associated cholangitis<ref>{{Cite journal  | last1 = Barnabas | first1 = A. | last2 = Chapman | first2 = RW. | title = Primary sclerosing cholangitis: is any treatment worthwhile? | journal = Curr Gastroenterol Rep | volume = 14 | issue = 1 | pages = 17-24 | month = Feb | year = 2012 | doi = 10.1007/s11894-011-0230-8 | PMID = 22124849 }}</ref>).
*Sclerosing cholangitis<ref name=pmid18609677/> (IgG4-associated cholangitis<ref>{{Cite journal  | last1 = Barnabas | first1 = A. | last2 = Chapman | first2 = RW. | title = Primary sclerosing cholangitis: is any treatment worthwhile? | journal = Curr Gastroenterol Rep | volume = 14 | issue = 1 | pages = 17-24 | month = Feb | year = 2012 | doi = 10.1007/s11894-011-0230-8 | PMID = 22124849 }}</ref>).

Revision as of 18:47, 14 August 2014

IgG4-related systemic disease, also IgG4-related disease, is a disease characterized IgG4 positive plasma cells and fibrosis.[1]

There are several IgG4-related diseases:

References

  1. ↑ Khosroshahi, A.; Stone, JH. (Jan 2011). "A clinical overview of IgG4-related systemic disease.". Curr Opin Rheumatol 23 (1): 57-66. doi:10.1097/BOR.0b013e3283418057. PMID 21124086.
  2. ↑ 2.0 2.1 2.2 Kamisawa, T.; Okamoto, A. (Jul 2008). "IgG4-related sclerosing disease.". World J Gastroenterol 14 (25): 3948-55. PMID 18609677.
  3. ↑ Saab, ST.; Hornick, JL.; Fletcher, CD.; Olson, SJ.; Coffin, CM. (Apr 2011). "IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link?". Mod Pathol 24 (4): 606-12. doi:10.1038/modpathol.2010.226. PMID 21297584.
  4. ↑ Barnabas, A.; Chapman, RW. (Feb 2012). "Primary sclerosing cholangitis: is any treatment worthwhile?". Curr Gastroenterol Rep 14 (1): 17-24. doi:10.1007/s11894-011-0230-8. PMID 22124849.
Retrieved from "https://librepathology.org/w/index.php?title=IgG4-related_systemic_diseases&oldid=33044"